Close Menu

At the CED Life Sciences Conference this week, Sanofi CEO Chris Viehbacher said that researchers who work for big pharma tend to be the least innovative, reports Pharmalot's Ed Silverman. The best scientists, Viehbacher said, work for small biotechs — that's why Sanofi is reducing its internal research capacity and partnering with outside companies, biotechs, and universities to get R&D done.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that Herbert Tabor, who worked at the US National Institutes of Health for 77 years, has died at 101.

The World Bank is seeking approval for a $12 billion plan to provide low-income nations with funds to procure SARS-CoV-2 vaccines, according to Reuters.

Science writes that public health officials and others are debating whether cycle threshold values should be included on SARS-CoV-2 results.

In Nucleic Acids Research this week: online database of SARS-CoV-2 protein structures, atlas of the human brain, and more.